Limonest, France

Jacques C Liautaud


Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • Limonest, FR (1976 - 1984)
  • 69 760 Limonest, FR (1989)

Company Filing History:


Years Active: 1976-1989

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Jacques C Liautaud: Pioneering Prothrombin Complex Concentrates

Introduction

Jacques C Liautaud, based in Limonest, France, is a notable inventor recognized for his contributions to the field of medical science, particularly in the area of blood coagulation. With a total of six patents to his name, Liautaud's work focuses on the preparation of prothrombin complex concentrates which are essential for addressing blood coagulation difficulties.

Latest Patents

Among his latest patents, Jacques C Liautaud has developed innovative procedures for the preparation of intravenously administered prothrombin complex concentrates. Notably, he has patented a procedure that involves the adsorption and elution of prothrombinogenic compounds along with antithrombin III (AT III). This unique method requires the use of an adsorbing agent that can effectively bind both compounds in the presence of heparin during the elution stage. The resulting products aim to significantly improve treatment options for patients facing blood coagulation issues.

Career Highlights

Throughout his career, Jacques C Liautaud has made significant advancements in medical technology. He has been associated with reputable companies such as Institut Merieux and Société Anonyme Dite: L'Oréal, where he applied his expertise in developing breakthroughs in medical treatments.

Collaborations

Liautaud's journey in the field of innovation has been enriched by collaborations with esteemed professionals such as Jean F Pla and Robert A Plan. Their shared insights and teamwork have contributed to the successful development of his patented technologies.

Conclusion

Jacques C Liautaud embodies the spirit of innovation in medical science through his focused efforts on prothrombin complex concentrates. His patents not only represent his dedication to advancing medical treatments but also highlight the importance of collaboration and continuous research in overcoming challenges related to blood coagulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…